Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Global HealthBOM:543654 -0.04%97 PEG Ratio is 2.21 as of Aug. 26, 2026, which is 25% above its 10-year median of 1.77. GuruFocus rates BOM:543654 with a GF Score™ of 97/100 and a GF Value™ of ₹1,562.98 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 226 Healthcare Providers & Services companies, Global Health ranks worse than 68.14% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Global Health's PEG Ratio or its related term are showing as below:
BOM:543654'
s PEG Ratio Range Over the Past 10 Years
Min: 1.62 Med: 1.77 Max: 2.21
Current: 2.21
During the past 7 years, Global Health's highest PEG Ratio was 2.21. The lowest was 1.62. And the median was 1.77.
BOM:543654's PEG Ratio is ranked worse than 68.14% of 226
companies
in the Healthcare Providers & Services industry
Industry Median: 1.475
vs BOM:543654: 2.21
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Global Health PEG Ratio Related Terms
Global Health PEG Ratio Historical Data
* Premium members only.
The historical data trend for Global Health's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Global Health's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Global Health PEG Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Global Health's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Global Health's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Global Health (BOM:543654) has a PEG Ratio of 2.21 as of Aug. 26, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Global Health and its competitors. This is 25% above median its historical median of 1.77. Over the past decade, Global Health's PEG Ratio has ranged from 1.62 to 2.21. According to the industry distribution chart, Global Health ranks #154 out of 226 companies in the Healthcare Providers & Services industry, placing it in the top 68.1%.
Is Global Health's PEG Ratio too high?
Global Health's current PEG Ratio of 2.21 is 25% above median its 10-year median of 1.77. Over the past 10 years, this metric has ranged from a low of 1.62 to a high of 2.21. The Healthcare Providers & Services industry median PEG Ratio is 1.48. Global Health's value of 2.21 is 49.8% above this industry median. Based on the distribution chart, Global Health ranks #154 out of 226 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Global Health has a GF Score™ of 97/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Global Health's PEG Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Global Health ranks #154 out of 226 companies for PEG Ratio. This places Global Health in the lower half of its industry. The industry median PEG Ratio is 1.48. Global Health's value of 2.21 is 49.8% above this benchmark. Historically, Global Health's own PEG Ratio has ranged from 1.62 to 2.21 over the past decade. While the company's 10-year median is 1.77 vs. the industry median of 1.48, Global Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Healthcare Providers & Services company?
The median PEG Ratio among Healthcare Providers & Services companies is 1.48, based on 226 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Global Health's current PEG Ratio of 2.21 is 49.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Global Health and its competitors. For the Healthcare Providers & Services industry, the median PEG Ratio is 1.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Global Health's current PEG Ratio is 2.21, which is 25% above median its own 10-year median of 1.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Health stock overvalued right now?
Based on GuruFocus' analysis, Global Health (BOM:543654) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,562.98, compared to a current price of ₹1,404.70 — trading 10.1% below its estimated fair value. The current PEG Ratio is 2.21, which is 25% above median its 10-year median of 1.77 and 49.8% above the Healthcare Providers & Services industry median of 1.48. Global Health's overall GF Score™ is 97/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Global Health (BOM:543654), the current PEG Ratio is 2.21 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Global Health (BOM:543654) Overvalued in 2026?
Based on GuruFocus' analysis, Global Health stock appears to be undervalued.
The current stock price of ₹1,404.70 is trading 10.1% below its estimated GF Value™ of ₹1,562.98.
GuruFocus considers Global Health to be Modestly Undervalued.
Key valuation signals for BOM:543654:
PEG Ratio: 2.21 (25% above median its 10-year median of 1.77)
GF Value™: ₹1,562.98 vs. price of ₹1,404.70 (10.1% below fair value)
Industry Position: 49.8% above the Healthcare Providers & Services median (#154 of 226)
No single metric tells the full story. See the BOM:543654 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Global Health Ltd operates as a private multi-specialty tertiary care provider operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. Under the Medanta brand, it has a network of hospitals in operation (Gurugram, Indore, Ranchi, and Lucknow), a hospital that is under construction with an operational outpatient facility (Patna), and a hospital (Noida) planned for development. The Group operates Healthcare services as a single business segment in India, constituting a single geographical segment.
97GF Score
Get the complete analysis for BOM:543654
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543654 has been successfully added to your 
